Artisan Acquisition Corp.

Artisan Acquisition Corp.

ARTAU
Artisan Acquisition Corp.US flagNASDAQ Capital Market
10.15
USD
- -
- -
Artisan Acquisition Corp.
ARTAU
(NASDAQ Capital Market)

Recent

price

10.15

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
Artisan Acquisition Corp. (ARTAU) operates as a blank check company, or special purpose acquisition company (SPAC), incorporated in 2021 and headquartered in Grand Cayman, Cayman Islands; the firm focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities, primarily targeting operations or prospects in high-growth healthcare, consumer, and technology sectors, with an emphasis on companies positioned for success in Greater China. It conducts no significant independent operations and generates no revenues, relying instead on its initial public offering proceeds of approximately $339 million raised in May 2021, underwritten by Credit Suisse, UBS Investment Bank, and others, to pursue such transactions globally. The company trades units on Nasdaq under the ticker ARTAU. In May 2022, Artisan Acquisition Corp. completed a reverse merger transaction with Prenetics Group Limited, a Hong Kong-based leader in genomic and diagnostic testing, pursuant to a business combination agreement originally announced in September 2021 that valued the combined entity at an enterprise value of approximately $1.25 billion and expected to deliver up to $459 million in gross proceeds, including PIPE investments and forward purchase agreements; this de-SPAC deal resulted in Prenetics acquiring Artisan, with the transaction approved by shareholders on May 9, 2022, and closing on May 17, 2022, after which Artisan's standalone activities ceased as it became part of the surviving public entity trading under Prenetics' ticker. As of late 2025, ARTAU units continue to trade on Nasdaq with limited volume and a share price around $10, though marked as potentially delisted, reflecting the completed merger's legacy structure without further independent strategic developments or new business combinations reported. No additional acquisitions, funding rounds, product launches, or operational shifts have occurred for Artisan since the Prenetics merger.